The government is reviewing making the expense for post-nuclear power treatment—used for decommissioning nuclear power plants and handling radioactive waste—more realistic. The expense has been frozen ...

Who is this for? The person who never remembers to charge their phone overnight. Anker’s MagGo power bank was one of the first Qi2-certified products to come to market — and it’s still one of the most ...

A mum with multiple sclerosis has become the first patient in the UK to receive an experimental treatment that could slow or even stop progression of the disease. Emily Henders, 37, was given an ...

Former President Joe Biden, who was diagnosed with an aggressive form of prostate cancer in May, completed a course of radiation treatment Monday, his office said. Biden underwent several weeks of ...

The drug sulthiame reduces the number of breathing pauses and improves sleep quality in patients with obstructive sleep apnea, according to a European clinical study in which the University of ...

Nuclear energy is a form of energy released from the nucleus, the core of atoms, made up of protons and neutrons. This source of energy can be produced in two ways: fission – when nuclei of atoms ...

BIO-UV Group has completed the first commercial deployment of its containerised BIO-SEA ballast water treatment system (BWTS) at Port-la-Nouvelle in southern France, supporting the installation of the ...

Biden, 82, celebrated the milestone at Penn Medicine Radiation Oncology in Philadelphia by taking part in the traditional ringing of the bell, a ritual that marks the end of treatment for a cancer ...

1.38 million gallons of raw sewage spilled into the James River in Hopewell, Virginia on July 12. The spill, caused by an electrical issue at the Hopewell Water Renewal plant, has been contained and ...

Salk Institute scientists discovered that bile acids in the liver can weaken immune cell function, making immunotherapy less effective against liver cancer. They pinpointed specific bile acids that ...

Oct 23 (Reuters) - The U.S. Food and Drug Administration has approved British drugmaker GSK's (GSK.L), opens new tab blood cancer drug, Blenrep, in one combination regimen, the company said on ...